SMT Sahajanand Medical Technologies a renowned medical device company at the forefront of innovative patient care in the cardiovascular segment has made an announcement about the Fire Trial in HBR patients at the prestigious TCT Transcatheter Cardiovascular Therapeutics Conference held in California.
A drug-eluting resorbable scaffold was superior to angioplasty in treating infrapopliteal artery disease and chronic limb-threating ischemia and was noninferior for safety in the LIFE-BTK trial.
CLASP IID One-year Data Confirm Safety and Efficacy of Edwards Pascal System for Degenerative Mitral Regurgitation dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.